On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.
On October 30, 2024, the Patient Engagement Advisory Committee will meet virtually to discuss and make recommendations on Patient-Centered Informed Consent in Clinical Study of FDA-Regulated Medical Products.
FDA has established docket FDA-2024-N-3924 for public comment on this meeting. The docket will close on January 21, 2025.
The FDA's Center for Devices and Radiological Health (CDRH) has contracted with the architectural firm HKS, Inc., to reimagine the home as an integral part of the health care system.
